Archive
CHEPLAPHARM moves into new 2500 square meter office building at Greifswald’s Business Park Ziegelhof
On December 1st CHEPLAPHARM Arzneimittel GmbH moved into a new prestigious office building at Ziegelhof Business Park in the outskirts of the…
Read moreCHEPLAPHARM Arzneimittel GmbH launches 100 million EURO investment program
The pharmaceutical firm CHEPLAPHARM Arzneimittel GmbH has embarked on the biggest ever investment program in the history of the company.
This…
Read moreCHEPLAPHARM continues its rapid growth: 50% sales increase in 2013 compared to the previous year.
Additionally, CHEPLAPHARM acquires Glenwood LLC based in New York, USA.
CHEPLAPHARM continues its rapid growth in 2013. The increase in sales…
Read moreCHEPLAPHARM acquires the rights for VESANOID® and ROHYPNOL® - largest investment since company´s existence.
Products are attained from F. Hoffmann-La Roche and will be exported to more than 90 countries.
Mesekenhagen-based CHEPLAPHARM Arzneimittel GmbH from…
Read moreCHEPLAPHARM attains the rights for HEMINEVRIN®/DISTRANEURIN®
Pharmaceutical product was taken over from AstraZeneca and is distributed in Europe
CHEPLAPHARM, headquartered in Mesekenhagen (Mecklenburg-Western…
Read more